ValiRx (VAL) Competitors GBX 0.61 +0.01 (+2.00%) As of 08/1/2025 12:17 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock VAL vs. NOG, HNR, SUN, EOG, WRES, EQT, CRC, WEB, NBL, and FTOShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include Nostrum Oil & Gas (NOG), Highlands Natural Resources (HNR), Surgical Innovations Group (SUN), Europa Oil & Gas (EOG), W Resources (WRES), EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), and 2059984 (FTO.L) (FTO). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. Its Competitors Nostrum Oil & Gas Highlands Natural Resources Surgical Innovations Group Europa Oil & Gas W Resources EQTEC Circle Property Webis 18564 (NBL.L) 2059984 (FTO.L) Nostrum Oil & Gas (LON:NOG) and ValiRx (LON:VAL) are both small-cap petroleum and natural gas companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, media sentiment, analyst recommendations and dividends. Is NOG or VAL more profitable? Nostrum Oil & Gas has a net margin of -59.05% compared to ValiRx's net margin of -20,554.01%. Nostrum Oil & Gas' return on equity of 74.84% beat ValiRx's return on equity.Company Net Margins Return on Equity Return on Assets Nostrum Oil & Gas-59.05% 74.84% 1.53% ValiRx -20,554.01%-55.84%-35.98% Do analysts recommend NOG or VAL? Nostrum Oil & Gas currently has a consensus price target of GBX 4, indicating a potential upside of 1.52%. Given Nostrum Oil & Gas' stronger consensus rating and higher possible upside, research analysts plainly believe Nostrum Oil & Gas is more favorable than ValiRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nostrum Oil & Gas 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00ValiRx 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in NOG or VAL? 22.3% of Nostrum Oil & Gas shares are owned by institutional investors. 44.3% of Nostrum Oil & Gas shares are owned by insiders. Comparatively, 18.3% of ValiRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better earnings and valuation, NOG or VAL? ValiRx has lower revenue, but higher earnings than Nostrum Oil & Gas. ValiRx is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNostrum Oil & Gas£206.12M0.05-£121.71M-£29.66-0.13ValiRx£27.78K83.64-£5.71M-£1.48-0.41 Does the media refer more to NOG or VAL? In the previous week, Nostrum Oil & Gas had 1 more articles in the media than ValiRx. MarketBeat recorded 2 mentions for Nostrum Oil & Gas and 1 mentions for ValiRx. ValiRx's average media sentiment score of -0.20 beat Nostrum Oil & Gas' score of -0.30 indicating that ValiRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nostrum Oil & Gas 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral ValiRx 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, NOG or VAL? Nostrum Oil & Gas has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, ValiRx has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. SummaryNostrum Oil & Gas beats ValiRx on 11 of the 15 factors compared between the two stocks. Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£2.32M£134.47M£5.48B£3.03BDividend Yield0.63%3.74%4.73%5.02%P/E Ratio-0.413.7828.67176.75Price / Sales83.644,246.60373.90264,362.43Price / Cash62.5013.1935.4527.97Price / Book0.2339.388.274.53Net Income-£5.71M-£90.99M£3.24B£5.90B7 Day Performance-4.23%-1.82%-3.69%12.58%1 Month Performance7.37%11.25%4.33%6.10%1 Year Performance-78.14%189.83%25.95%71.59% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 0.61+2.0%N/A-78.1%£2.32M£27.78K-0.415,450Gap UpNOGNostrum Oil & Gas0.4543 of 5 starsGBX 3-12.3%GBX 6+100.0%-27.0%£7.90M£206.12M-0.1030Analyst ForecastGap DownHNRHighlands Natural ResourcesN/AN/AN/AN/A£6.95M£1.02M-0.9616Gap DownHigh Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.66-6.4%N/A-3.1%£6.11M£12.54M-21.1180EOGEuropa Oil & GasN/AGBX 0.52+9.3%N/A-53.7%£4.98M£3.57M-0.732,850Gap DownWRESW ResourcesN/AN/AN/AN/A£3.89M£3.47M-0.4366Gap DownEQTEQTECN/AGBX 0.50-3.7%N/A-62.7%£1.29M£3.85M-2.95740Gap DownCRCCircle PropertyN/AN/AN/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AN/AN/AN/A£157K£49.70M14.1350Gap DownNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000 Related Companies and Tools Related Companies Nostrum Oil & Gas Alternatives Highlands Natural Resources Alternatives Surgical Innovations Group Alternatives Europa Oil & Gas Alternatives W Resources Alternatives EQTEC Alternatives Circle Property Alternatives Webis Alternatives 18564 (NBL.L) Alternatives 2059984 (FTO.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VAL) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.